Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred K Cheung

Showing results (231-240 of 262) with videos related to

Pageof 27
Sort By:
Kidney360|April 4, 2022
Abnormalities in Cardiac Structure and Function among Individuals with CKD: The COMBINE TrialAnn A Wang, Xuan Cai, Anand Srivastava, et al.
Journal of the American Society of Nephrology : JASN|October 13, 2018
Prediction of Arteriovenous Fistula Clinical Maturation from Postoperative Ultrasound Measurements: Findings from the Hemodialysis Fistula Maturation StudyMichelle L Robbin, Tom Greene, Michael Allon, et al.
The New England Journal of Medicine|November 10, 2015
A Randomized Trial of Intensive versus Standard Blood-Pressure Control, Jackson T Wright, Jeff D Williamson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2025
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY TrialKaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, et al.
The New England Journal of Medicine|December 20, 2002
Effect of dialysis dose and membrane flux in maintenance hemodialysisGarabed Eknoyan, Gerald J Beck, Alfred K Cheung, et al.
Clinical Trials (London, England)|June 7, 2014
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)Walter T Ambrosius, Kaycee M Sink, Capri G Foy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 1, 2024
Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trialKaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, et al.
The New England Journal of Medicine|May 19, 2021
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control, Cora E Lewis, Lawrence J Fine, et al.
The New England Journal of Medicine|August 24, 2017
Cost-Effectiveness of Intensive versus Standard Blood-Pressure ControlAdam P Bress, Brandon K Bellows, Jordan B King, et al.
Hypertension (Dallas, Tex. : 1979)|November 10, 2021
SPRINT Revisited: Updated Results and ImplicationsJackson T Wright, Paul K Whelton, Karen C Johnson, et al.
Pageof 27

Showing results (231-240 of 262) with videos related to

Sort By:
Pageof 27
Kidney360|April 4, 2022
Abnormalities in Cardiac Structure and Function among Individuals with CKD: The COMBINE TrialAnn A Wang, Xuan Cai, Anand Srivastava, et al.
Journal of the American Society of Nephrology : JASN|October 13, 2018
Prediction of Arteriovenous Fistula Clinical Maturation from Postoperative Ultrasound Measurements: Findings from the Hemodialysis Fistula Maturation StudyMichelle L Robbin, Tom Greene, Michael Allon, et al.
The New England Journal of Medicine|November 10, 2015
A Randomized Trial of Intensive versus Standard Blood-Pressure Control, Jackson T Wright, Jeff D Williamson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2025
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY TrialKaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, et al.
The New England Journal of Medicine|December 20, 2002
Effect of dialysis dose and membrane flux in maintenance hemodialysisGarabed Eknoyan, Gerald J Beck, Alfred K Cheung, et al.
Clinical Trials (London, England)|June 7, 2014
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)Walter T Ambrosius, Kaycee M Sink, Capri G Foy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 1, 2024
Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trialKaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, et al.
The New England Journal of Medicine|May 19, 2021
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control, Cora E Lewis, Lawrence J Fine, et al.
The New England Journal of Medicine|August 24, 2017
Cost-Effectiveness of Intensive versus Standard Blood-Pressure ControlAdam P Bress, Brandon K Bellows, Jordan B King, et al.
Hypertension (Dallas, Tex. : 1979)|November 10, 2021
SPRINT Revisited: Updated Results and ImplicationsJackson T Wright, Paul K Whelton, Karen C Johnson, et al.
Pageof 27